课题基金 / 基金详情

项目摘要

项目成果

Nicole Baumgarth的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
in part by studies conducted during the initial funding period of this grant, suggests that immediate early exposure of B cells to infection-induced innate signals shape the responses of B cells. Little is known about the nature of these signals and the mechanisms by which they affect the B cell response. The working hypothesis to be tested here is that infection-induced local innate immune signals differentially regulate various B cell subsets involved in the induction of protective immunity to influenza virus infection. The long-term objective of the studies is to determine how respiratory tract immunity to viral infections is induced and regulated. The objective of this proposal is to determine the mechanisms by which innate immune signals, particularly type I IFN shape the quality and magnitude of antiviral B cell responses. This is based on studies during the last funding period which showed type I IFN as a major infection-induced B cell stimulus in regional lymph nodes within 2 days of infection. To achieve our objective three Specific Aims will be carried out. Specific Aim #1 will determine the mechanisms by which direct IFNR-signals received by B cells affect the magnitude and protective capacity of individual B cell response components to influenza: B-1 cells, extrafollicular foci and germinal center responses. Specific Aim #2 will determine the role of toll-like receptor (TLR) 3 and 7-mediated signals on antiviral B cell response regulation to influenza infection and their integration with stimuli provided by the B cell receptor and/or T cell help. In Specific Aim #3 the effects of IFNR-mediated B cell stimulation on local CD4 T cell responses to influenza virus infection and particular the affects on CD40-CD40L mediated help will be investigated. In vitro and in vivo tests are aided by the use of virus-specific T cell receptor transgenic mice. Completion of these studies will contribute to a better understanding of the processes that regulate the induction of protective antiviral B cell responses to influenza virus. Project Description Page 6
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
sIgM-FcμR Interactions Regulate Early B Cell Activation and Plasma Cell Development after Influenza Virus Infection.
SIGM-FCμR相互作用调节流感病毒感染后的早期B细胞激活和浆细胞发育。
DOI: 10.4049/jimmunol.1700560
发表时间: 2017-09-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Nguyen TTT, Graf BA, Randall TD, Baumgarth N]
通讯作者: Baumgarth N
B-1 Cell Heterogeneity and the Regulation of Natural and Antigen-Induced IgM Production.
B-1细胞异质性以及自然和抗原诱导的IgM产生的调节。
DOI: 10.3389/fimmu.2016.00324
发表时间: 2016
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Baumgarth N]
通讯作者: Baumgarth N
The role of innate signals in B cell immunity to influenza virus.
先天信号在 B 细胞对流感病毒的免疫中的作用。
DOI: 10.2741/s360
发表时间: 2013
期刊: Frontiers in bioscience (Scholar edition)
影响因子: --
作者: [Priest,StephenO, Baumgarth,Nicole]
通讯作者: Baumgarth,Nicole
DOI: 10.1002/eji.200939798
发表时间: 2010-02
期刊: EUROPEAN JOURNAL OF IMMUNOLOGY
影响因子: 5.4
作者: [Rothaeusler, Kristina, Baumgarth, Nicole]
通讯作者: Baumgarth, Nicole
17
    Antibody-mediated immunity to Borrelia burgdorferi
    • 批准号:
      10368140
    • 项目类别:
    • 资助金额:
      $12.33万
    • 财政年份:
      2021
    • 负责人:
      Nicole Baumgarth
    • 依托单位:
    Antibody-mediated immunity to Borrelia burgdorferi
    • 批准号:
      10559504
    • 项目类别:
    • 资助金额:
      $44.27万
    • 财政年份:
      2021
    • 负责人:
      Nicole Baumgarth
    • 依托单位:
    Antibody-mediated immunity to Borrelia burgdorferi
    • 批准号:
      10731568
    • 项目类别:
    • 资助金额:
      $43.3万
    • 财政年份:
      2021
    • 负责人:
      Nicole Baumgarth
    • 依托单位:
    B-1 cells, IgM and Protective Humoral Immunity to Influenza
    • 批准号:
      10681028
    • 项目类别:
    • 资助金额:
      $40.73万
    • 财政年份:
      2019
    • 负责人:
      Nicole Baumgarth
    • 依托单位:
    国内基金
    海外基金
    Agonist-GPR119-Gs复合物的结构生物学研究
    • 批准号:
      32000851
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      乔安娜
    • 依托单位: